Bork Jacqueline T, Heil Emily L, Leekha Surbhi, Fowler Randal C, Hanson Nancy D, Majumdar Anjali, Johnson J Kristie
University of Maryland School of Medicine, Department of Medicine, Division of Infectious Diseases, Baltimore, MD.
University of Maryland School of Pharmacy, Baltimore, MD.
Diagn Microbiol Infect Dis. 2017 Dec;89(4):328-333. doi: 10.1016/j.diagmicrobio.2017.08.020. Epub 2017 Oct 12.
We analyzed the effects of different cefepime MIC breakpoints on Enterobacteriaceae cefepime susceptibility and the presence of AmpC and extended-spectrum β-lactamase (ESBL) genes within the cefepime MIC interpretative categories.
Using Enterobacteriaceae susceptibility data from 2013 comparisons of MIC breakpoints were performed using Pearson's chi-squared test. Molecular testing on a subset of isolates was done.
Among 3784 non-duplicate clinical isolates, cefepime susceptibility decreased from 97.6% to 96.1% to 93.7% for CLSI 2013, CLSI 2014, and EUCAST 2011, respectively. In ceftriaxone non-susceptible isolates, cefepime susceptibility decreased from 79% to 66% (P<0.0001) using CLSI 2013 and 2014, respectively, which was greater and statistically significant for Escherichia coli and Klebsiella spp. but not for Enterobacter spp. (P=0.06). Isolates with MIC ≤1μg/mL more often harbored AmpC (77%) than ESBL (18%) genes.
Lower cefepime MIC breakpoints decrease cefepime susceptibility for isolates harboring ESBLs, while sparing the majority of those with AmpCs.
我们分析了不同头孢吡肟MIC折点对肠杆菌科细菌头孢吡肟敏感性的影响,以及在头孢吡肟MIC解释类别中AmpC和超广谱β-内酰胺酶(ESBL)基因的存在情况。
利用2013年肠杆菌科细菌的药敏数据,采用Pearson卡方检验对MIC折点进行比较。对一部分分离株进行了分子检测。
在3784株非重复临床分离株中,对于CLSI 2013、CLSI 2014和EUCAST 2011,头孢吡肟敏感性分别从97.6%降至96.1%再降至93.7%。在对头孢曲松不敏感的分离株中,分别使用CLSI 2013和2014时,头孢吡肟敏感性从79%降至66%(P<0.0001),这在大肠埃希菌和克雷伯菌属中变化更大且具有统计学意义,但在肠杆菌属中无此变化(P=0.06)。MIC≤1μg/mL的分离株携带AmpC基因(77%)的频率高于携带ESBL基因(18%)的频率。
较低的头孢吡肟MIC折点会降低携带ESBLs分离株的头孢吡肟敏感性,而对大多数携带AmpC的分离株影响较小。